Major Depressive Disorder Clinical Trials
Major Depressive Disorder clinical trials evaluate new treatments, behavioral therapies, and medications for major Depressive Disorder. Corterve compiles actively recruiting Major Depressive Disorder studies from the ClinicalTrials.gov registry so you can search by location and eligibility criteria. Participation is always voluntary and confidential. This information is educational and not medical advice — talk with a licensed clinician about whether a study is right for you.
Recruiting Major Depressive Disorder studies
- DBS for DepressionNCT03437928NABaylor College of MedicineDallas, Texas
- A Study to Evaluate the Effectiveness of DT-101 as an Adjunctive Treatment in Patients With DepressionNCT07610473PHASE2Draig Therapeutics LtdPhoenix, Arizona
- Evaluating Conversational Artificial Intelligence for Depression ManagementNCT07105397NAGeorge Mason UniversityFairfax, Virginia
- Mindful Self-Compassion for Anxiety Disorders and DepressionNCT05671419NAGeorgetown UniversityWashington D.C., District of Columbia
- Study of Lumateperone as Adjunctive Therapy in the Treatment of Patients With Major Depressive DisorderNCT05850689PHASE3Intra-Cellular Therapies, Inc.Huntsville, Alabama
- A Phase 3 Trial of DT120 for Major Depressive Disorder (Ascend)NCT07592689PHASE3Definium Therapeutics US, Inc.Gilbert, Arizona
- Natural History of Depression, Bipolar Disorder and Suicide RiskNCT06462196National Institute of Mental Health (NIMH)Bethesda, Maryland
- Study of Neuro-Cognitive Correlates of Pediatric Anxiety DisordersNCT00018057PHASE2National Institute of Mental Health (NIMH)Bethesda, Maryland
- A Phase 2 Study of Zelquistinel or Placebo for the Reduction of Symptoms of Major Depressive DisorderNCT07115329PHASE2Syndeio Biosciences, IncPhoenix, Arizona
- Long-Term Study to Assess the Safety and Tolerability of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)NCT06966401PHASE3Neurocrine BiosciencesHuntsville, Alabama
- A Study to Evaluate the Maintenance Effect of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)NCT07196501PHASE3Neurocrine BiosciencesOceanside, California
- Clinical Assessment of Response in the Treatment of Depression With Daytime Sleepiness Using SolriamfetolNCT07484217PHASE3Axsome Therapeutics, Inc.Tucson, Arizona
Major Depressive Disorder trials by state
Major Depressive Disorder trials by metro
Frequently asked questions
- How do I find recruiting Major Depressive Disorder clinical trials?
- Corterve aggregates actively recruiting Major Depressive Disorder studies from the public ClinicalTrials.gov registry. Browse the studies listed on this page or take a free health assessment to see trials you may qualify for based on your profile.
- Are Major Depressive Disorder clinical trials free to join?
- Study participation is typically free — research sponsors cover the cost of the investigational treatment and study-related visits. Many trials also compensate participants for time and travel. Details vary by study.
- Who can take part in a Major Depressive Disorder clinical trial?
- Each study has its own eligibility criteria (for example age, disease stage, and prior treatments). This page is general information and not medical advice; discuss any specific trial with your healthcare provider to confirm whether it is appropriate for you.